Share-based Payment Arrangement, Expense of Emergent BioSolutions Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Emergent BioSolutions Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Emergent BioSolutions Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $4,800,000, a 109% increase year-over-year.
  • Emergent BioSolutions Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $15,200,000, a 14% decline year-over-year.
  • Emergent BioSolutions Inc. annual Share-based Payment Arrangement, Expense for 2024 was $18,000,000, a 22% decline from 2023.
  • Emergent BioSolutions Inc. annual Share-based Payment Arrangement, Expense for 2023 was $23,100,000, a 49% decline from 2022.
  • Emergent BioSolutions Inc. annual Share-based Payment Arrangement, Expense for 2022 was $45,100,000, a 6.4% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Emergent BioSolutions Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,200,000 $4,800,000 +$2,500,000 +109% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $12,700,000 $4,600,000 -$900,000 -16% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $13,600,000 $1,500,000 -$4,400,000 -75% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $18,000,000 $4,300,000 +$300,000 +7.5% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 $17,700,000 $2,300,000 -$1,700,000 -42% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $19,400,000 $5,500,000 -$2,800,000 -34% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $22,200,000 $5,900,000 -$900,000 -13% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $23,100,000 $4,000,000 -$7,700,000 -66% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $30,800,000 $4,000,000 -$7,200,000 -64% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $38,000,000 $8,300,000 -$4,000,000 -33% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $42,000,000 $6,800,000 -$3,100,000 -31% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $45,100,000 $11,700,000 +$1,600,000 +16% 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
Q3 2022 $43,500,000 $11,200,000 +$800,000 +7.7% 01 Jul 2022 30 Sep 2022 10-Q 11 Dec 2023 2023 Q3
Q2 2022 $42,700,000 $12,300,000 +$900,000 +7.9% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $41,800,000 $9,900,000 -$600,000 -5.7% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $42,400,000 $10,100,000 -$700,000 -6.5% 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2024 2023 FY
Q3 2021 $43,100,000 $10,400,000 +$400,000 +4% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $42,700,000 $11,400,000 -$13,000,000 -53% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $55,700,000 $10,500,000 +$3,900,000 +59% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $51,800,000 $10,800,000 01 Oct 2020 31 Dec 2020 10-K/A 11 Dec 2023 2022 FY
Q3 2020 $10,000,000 +$3,900,000 +64% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $24,400,000 +$16,300,000 +201% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $6,600,000 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q3 2019 $6,100,000 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $8,100,000 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2

Emergent BioSolutions Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $18,000,000 -$5,100,000 -22% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 $23,100,000 -$22,000,000 -49% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $45,100,000 +$2,700,000 +6.4% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 $42,400,000 -$9,400,000 -18% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2024 2023 FY
2020 $51,800,000 +$25,100,000 +94% 01 Jan 2020 31 Dec 2020 10-K/A 11 Dec 2023 2022 FY
2019 $26,700,000 +$3,500,000 +15% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $23,200,000 +$8,000,000 +53% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021 2020 FY
2017 $15,200,000 -$3,300,000 -18% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $18,500,000 +$2,652,000 +17% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $15,848,000 +$3,019,000 +24% 01 Jan 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
2014 $12,829,000 +$1,591,000 +14% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $11,238,000 +$123,000 +1.1% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $11,115,000 +$376,000 +3.5% 01 Jan 2012 31 Dec 2012 10-K 09 Mar 2015 2014 FY
2011 $10,739,000 +$3,676,000 +52% 01 Jan 2011 31 Dec 2011 10-K 10 Mar 2014 2013 FY
2010 $7,063,000 01 Jan 2010 31 Dec 2010 10-K 08 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.